Traws Pharma, Inc. (TRAW) Q2 2025 Earnings
Traws Pharma, Inc. reported Q2 2025 revenue of $2.7M (+4780.4% YoY), beat analyst consensus of $60.0K by $2.7M. Diluted EPS came in at $-0.34 (+96.1% YoY), beat the $-9.16 consensus by $8.82.
Financial Snapshot
Trailing eight quarters through Q2 2025
Q2 2025 Earnings FAQ
Common questions about Traws Pharma, Inc.'s Q2 2025 earnings report.
Traws Pharma, Inc. (TRAW) reported Q2 2025 earnings on November 13, 2025 before market open.
Traws Pharma, Inc. reported revenue of $2.7M and diluted EPS of $-0.34 for Q2 2025.
Revenue beat the consensus estimate of $60.0K by $2.7M. EPS beat the consensus estimate of $-9.16 by $8.82.
Compared to the same quarter a year prior, revenue grew 4780.4% from $56.0K a year earlier and diluted EPS grew 96.1% from $-8.81.
You can read the 8-K earnings release (0001104659-25-110829) and the 10-Q periodic report (0001558370-25-011469) directly on SEC EDGAR. The filing index links above go to sec.gov.